Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2002
Business Overview: Humana is a major health benefits company offering coordinated health insurance coverage through traditional and Internet-based plans for employer groups and government-sponsored programs. As of June 30, 2002, the company served approximately 6.6 million medical insurance members and 2.2 million specialty product members. Operations are divided into two segments: Commercial (employer groups) and Government (Medicare+Choice, Medicaid, TRICARE).
Key Financial Metrics
Revenue and Profitability (Six Months Ended June 30, 2002):
- Total Revenues: $5,564.5 million (up 12.2% from $4,961.3 million in 2001).
- Premium Revenues: $5,385.6 million (up 11.0% from 2001).
- Net Income: $92.1 million ($0.55 diluted EPS), compared to $51.7 million ($0.31 diluted EPS) in 2001.
- Income from Operations: $144.3 million (up from $95.4 million in 2001).
Cash Flow and Liquidity:
- Cash and Cash Equivalents: $450.7 million at June 30, 2002 (down from $651.4 million at Dec 31, 2001).
- Net Cash Used in Operating Activities: $183.9 million. Management notes that normalized operating cash flows (adjusting for Medicare+Choice timing) were positive at $32.7 million.
- Investing Activities: Net cash used of $6.3 million, primarily due to purchases of investment securities and property/equipment.
Debt and Capital Structure:
- Total Debt: $588.4 million ($265.0 million short-term; $323.4 million long-term).
- Stockholders' Equity: $1,621.1 million.
- Interest Expense: $8.8 million for the six-month period (down from $14.5 million in 2001).
Operational Ratios (Six Months):
- Medical Expense Ratio: 83.8% (up 30 basis points from 83.5% in 2001).
- SG&A Expense Ratio: 15.4% (up 40 basis points from 15.0% in 2001).
Material Changes vs. Prior Period
- Accounting Change (Goodwill): Humana adopted FAS 142 on January 1, 2002, ceasing the amortization of goodwill. This resulted in a significant increase in reported net income compared to 2001, where $27.2 million in goodwill amortization was recorded for the six-month period. Adjusted 2001 net income (excluding amortization) was $77.6 million.
- TRICARE Growth: Government segment revenues surged, driven by TRICARE premiums which increased 79.2% year-over-year to $963.3 million. This was due to the acquisition of Regions 2 and 5 business and expanded benefits mandated by Congress.
- Membership Shifts: Total medical membership increased 1.7% to 6.57 million. Commercial fully insured membership declined 1.0%, while TRICARE membership grew 2.0%. Medicare+Choice membership declined 15.3% due to strategic exits and attrition.
- Receivables: Total receivables increased $191.2 million (58.6%), primarily driven by TRICARE receivables related to change orders and bid price adjustments for expanded benefits.
Guidance, Outlook, and Risks
Management Commentary and Outlook:
- Commercial Segment: Management expects Commercial fully insured and ASO medical membership to increase 3.0% to 3.5% for the full year 2002. Premium yields are expected to remain in the 12% to 14% range.
- SG&A Outlook: Consolidated SG&A expense ratio is projected to range from 15.4% to 15.6% for the last two quarters of 2002.
- Capital Expenditures: Expected to be approximately $115 million for 2002, focused on technology initiatives and administrative facilities.
- Stock Repurchase: In July 2002, the Board authorized a $100 million share repurchase program. As of August 8, 2002, 1.4 million shares had been purchased for $16.9 million.
Risks and Contingencies:
- Government Contract Renewals: Medicare+Choice contracts are renewed annually; legislative proposals to revise reimbursement rates pose uncertainty. TRICARE contracts are up for extension in 2003, with a potential consolidation of regions by the Department of Defense.
- Legal Proceedings: Humana is involved in significant managed care industry class action litigation (subscriber and provider tracks) alleging RICO violations and breach of fiduciary duty. Discovery is set to commence in late 2002. Additionally, securities litigation regarding a prior acquisition (PCA) is set for trial in December 2002.
- Regulatory Environment: Increased scrutiny from state and federal regulators regarding claims payment practices, utilization management, and compliance with HIPAA and ERISA regulations.
- Medical Cost Inflation: Rising prescription drug costs and potential for catastrophic events or epidemics could increase medical expense ratios.
Investor Verification Checklist
- TRICARE Receivables Collection: Verify the collection status of the $181.7 million in TRICARE receivables related to change orders and bid price adjustments, which are expected to be collected by year-end 2002.
- Legal Exposure: Monitor the outcome of the "In re Managed Care Litigation" and the PCA securities trial scheduled for December 2002, as these could result in substantial damages.
- Government Contract Renewals: Track the renewal status of Medicare+Choice contracts and the outcome of TRICARE Region consolidation bids, as these represent a significant portion of revenue.
- Medical Expense Ratio Trends: Assess whether the rising medical expense ratio (83.8% for six months) stabilizes or continues to increase due to prescription drug costs and benefit expansions.
- Cash Flow Normalization: Review future cash flow statements to ensure the "normalized" operating cash flow metric remains positive, given the volatility caused by Medicare+Choice premium timing.